Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28a869d6fc950d50f6df03f549ca3afa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e809b17a159ce2f42f1a65a302c405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_416b393befd6f617ca982bb321398dcc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33d18d20c1e58d0ac0cdeb109f926ce9 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate |
2004-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16c099801048f7bdb3955afdaf1b04d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10b27e1c0fddccfe2c8900105609de9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70833a68a9f56e233b33c2d88726e463 |
publicationDate |
2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005014809-A1 |
titleOfInvention |
Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
abstract |
[PROBLEMS] To provide a polypeptide specific to liver cancer, a polynucleotide encoding the polypeptide, and an RNA molecule inhibiting the expression of the polypeptide. [MEANS FOR SOLVING PROBLEMS] A polypeptide containing the amino acid sequence of SEQ ID NO:1; a polypeptide having a homology of at least 80% with the amino acid sequence of SEQ ID NO:1 and having an immunogenicity of inducing the production of an antibody against a polypeptide containing the amino acid sequence of SEQ ID NO:1; nucleotide fragments thereof; a polynucleotide encoding the above polypeptide and its fragment; and an RNA molecule having a partial sequence corresponding to an mRNA encoding a polypeptide containing the amino acid sequence of SEQ ID NO:1. |
priorityDate |
2003-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |